Summary & Overview
Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview
DRG 616 addresses inpatient admissions for lower limb amputation associated with endocrine, nutritional, and metabolic disorders when a Major Complication or Comorbidity is present, encompassing cases such as amputation for advanced diabetic complications. Correct classification matters for inpatient reimbursement because the Major Complication or Comorbidity status increases resource intensity and influences Medicare payment.
DRG 616 Overview
DRG 616 covers inpatient hospital admissions for lower limb amputation procedures performed in the setting of underlying endocrine, nutritional, and metabolic disorders when a Major Complication or Comorbidity is present. Typical cases include amputations related to advanced diabetic foot disease, severe peripheral vascular compromise, or metabolic complications that increase clinical complexity. This Diagnosis-Related Group is important for Medicare payment because the presence of a Major Complication or Comorbidity increases relative resource use and affects the hospital reimbursement weight. Hospitals and coders must accurately document operative procedures and the qualifying comorbid conditions to align clinical care with appropriate Medicare Severity Diagnosis-Related Group assignment.